Dr Monteith discusses new guidelines on migraine treatment, and how to integrate new treatments for better outcomes.
An update on migraine guidelines: Integrating new therapies for better outcomes
Dr Monteith discloses consulting fees, or paid advisory boards, from Impel NeuroPharma, Lundbeck, Alder Pharmaceuticals, and Amgen Pharmaceuticals.